Identification of Natural RORγ Ligands that Regulate the Development of Lymphoid Cells

Male 0301 basic medicine Physiology [SDV]Life Sciences [q-bio] Mice, Transgenic [SDV.BC]Life Sciences [q-bio]/Cellular Biology [SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology Ligands Cell Line Mice Sterol 14-Demethylase 03 medical and health sciences Animals Humans Lymphocytes Molecular Biology [SDV.BC] Life Sciences [q-bio]/Cellular Biology Mice, Knockout [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology Cell Biology Nuclear Receptor Subfamily 1, Group F, Member 3 [SDV] Life Sciences [q-bio] Sterols Cholesterol Drosophila melanogaster HEK293 Cells Th17 Cells
DOI: 10.1016/j.cmet.2015.01.004 Publication Date: 2015-02-03T17:31:36Z
ABSTRACT
Mice deficient in the nuclear hormone receptor RORγt have defective development of thymocytes, lymphoid organs, Th17 cells, and type 3 innate lymphoid cells. RORγt binds to oxysterols derived from cholesterol catabolism, but it is not clear whether these are its natural ligands. Here, we show that sterol lipids are necessary and sufficient to drive RORγt-dependent transcription. We combined overexpression, RNAi, and genetic deletion of metabolic enzymes to study RORγ-dependent transcription. Our results are consistent with the RORγt ligand(s) being a cholesterol biosynthetic intermediate (CBI) downstream of lanosterol and upstream of zymosterol. Analysis of lipids bound to RORγ identified molecules with molecular weights consistent with CBIs. Furthermore, CBIs stabilized the RORγ ligand-binding domain and induced coactivator recruitment. Genetic deletion of metabolic enzymes upstream of the RORγt-ligand(s) affected the development of lymph nodes and Th17 cells. Our data suggest that CBIs play a role in lymphocyte development potentially through regulation of RORγt.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (48)
CITATIONS (203)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....